Strategic Alliances

print page

Palatin has two major strategic alliances.  One is with AstraZeneca for development and commercialization of melanocortin-based products for treatment of obesity, diabetes and metabolic syndrome.  The other is with Gedeon Richter, to co-develop and commercialize bremelanotide for FSD in the European Union, other European countries and additional selected countries.

Entering into alliances and partnerships with pharmaceutical companies to facilitate the development, manufacture, marketing, sale and distribution of product candidates we develop is an integral part of our corporate strategy.